SS-31 is studied in mitochondrial membrane and cardiolipin-associated models, including cellular oxidative-stress assays.
- Mitochondrial membranes
- Cardiolipin-associated models
- Oxidative-stress assays
Cardiolipin is why SS-31 papers exist
That membrane discussion is the file for this peptide. NAD+ papers about sirtuins and PARP are a cofactor file. MOTS-C papers about AMPK are a different peptide file.
Elamipretide is the name on the test title. The catalog name is SS-31.
Do not borrow the NAD+ mass
NAD+ task 157318 prints 929.05 mg. That mass is not an SS-31 result.
This page is laboratory education for adults 21 and older. It is not a dosing guide, a treatment plan, or a ranking of which material to use. Not for human or veterinary use.
SS-31 10 mg research questions
What is filed under SS-31?
Mitochondrial membranes, cardiolipin-associated models, and oxidative-stress assays.
What is the test title?
Elamipretide (SS-31) analysis, task 172219.
References and further reading
- PubMed literature index — SS-31 10 mg ↗
A continuously updated index of peer-reviewed biomedical literature. Study quality, model, and relevance must be assessed individually.
- FDA — Analytical Procedures and Methods Validation ↗
Regulatory guidance on analytical method development and validation.
- ICH Q2(R2) — Validation of Analytical Procedures ↗
International guidance on specificity, accuracy, precision, range, and robustness.
- Hoofnagle et al. — Recommendations for peptide storage and handling ↗
Peer-reviewed recommendations for peptide handling in quantitative laboratory workflows.
External links are provided for independent literature review. A link does not imply that every indexed paper supports the same conclusion or that findings apply beyond the model and conditions studied.
